I was disappointed to read the news recently about new data from a Phase 3 clinical trial of an investigational treatment for Angelman syndrome called OV101 (gaboxadol). Developed by Ovid Therapeutics, the experimental treatment did not appear to combat the complexities brought on by Angelman.
A Glass Half Full
— Sabrina L. Johnson

Sabrina L. Johnson wears hats as a wife, special needs mom, educator, freelance writer, and HR professional. Baking, reading, and gardening are her fun hats. When her daughter Juliana was diagnosed with Angelman syndrome in 2011, Sabrina searched for the right inspirational content. Not finding the positivity she craved, she began writing uplifting stories on her blog, Juliana’s Journal. Writing led to advocacy, and the e-book “Forward: First Steps on a Path to a Special Needs Life.” Sabrina writes to show that a life with challenges can still be viewed as a glass half full. She lives in Atlanta, Georgia with her husband, two daughters, and a very energetic Maltese.
Explore More Columns
Discussion
Discussion
Discussion
